// App-Quantinova.ai

4386 : CETSA as a new strategy to understand efficacy, adverse effects and resistance development of anticancer drugs

Researchers

Presenter

  • Par Nordlund

Principal Investigators

  • Sara Loof

  • Henritte Laursen

  • Anette Oberg

  • Johan Lengqvist

  • Rozbeh Jafari

  • Lingyun Dai

  • Ka DIam Go

  • Nayana Prabhu

  • Radoslaw Sobota

  • Andreas Larsson

  • Anna Jansson

  • Chris Heng Tan Soon

  • Lekshmy Sreekumar

  • Yan Ting Lim

  • Daniel Martines Molina

Medical Centers

  • Karolinska Institutet, Stockholm, Sweden

  • Nanyang Technological University, Singapore, Singapore.

  • A*STAR, singapore, Singapore

Locations

  • Sweden

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved